Search results
Bernie Sanders will grill Novo Nordisk's CEO over Ozempic and Wegovy prices
Quartz· 6 days agoCEO Lars Fruergaard Jørgensen will testify before the Senate's health committee after Sanders...
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
NBC Dallas Fort Worth· 5 days agoMore U.S. employers are covering a buzzy class of medications called GLP-1s for weight loss, a...
Novo Nordisk multibillion-dollar expansion in North Carolina appears imminent - Triangle Business...
The Business Journals· 6 days agoA multibillion-dollar expansion in Johnston County appears to be imminent for one of the world's...
Eli Lilly seeks FDA’s OK to expand Zepbound’s uses to include sleep apnea
Market Watch· 2 days agoEli Lilly & Co. said Friday that it has applied for U.S. regulatory approval to expand the use of...
Sanders hopes pressure will force down Ozempic price
Axios· 3 days agoSen. Bernie Sanders is trying to use the bully pulpit to lower the price of wildly popular anti-obesity drugs the same way he helped pushed drugmakers to...
Weight-loss options for US youth are hard to come by
WSAU Wausau· 6 days agoBy Robin Respaut and Chad Terhune (Reuters) - For many U.S. parents seeking help for a child with obesity, the most widely-endorsed treatment is out of...
Gateway - Quartz
Quartz· 5 days agoAfter dominating the market for weight loss drugs, Ozempic maker Novo Nordisk has set its sights on tackling treatments for heart disease next. Cardior, a Germany-based drug ...
Why Bernie Sanders’ Ozempic crusade is misguided
Dallas Morning News· 5 days agoIt’s not surprising that Sanders, one of the most vociferous critics of the pharmaceutical industry in Congress...
Eli Lilly Has a New Drug That Could Push the Stock Higher
Motley Fool via Yahoo Finance· 3 days agoShould you invest $1,000 in Eli Lilly right now? Before you buy stock in Eli... has no position in...
Inside WeightWatchers' shift on Wegovy, Mounjaro, other GLP-1s
Crain s Chicago Business· 6 days agoThe event comes at a time when every discussion about weight loss medications seems to involve glucagon-like peptide agonists. The healthcare industry is awash in companies standing up telehealth ...